Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$35.53 - $43.38 $176,903 - $215,989
4,979 New
4,979 $203,000
Q2 2022

Aug 09, 2022

SELL
$51.49 - $81.64 $3.47 Million - $5.51 Million
-67,470 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$60.03 - $76.49 $42,201 - $53,772
-703 Reduced 1.03%
67,470 $5.15 Million
Q4 2021

Feb 10, 2022

SELL
$47.97 - $62.21 $382,656 - $496,249
-7,977 Reduced 10.48%
68,173 $4.1 Million
Q3 2021

Nov 12, 2021

BUY
$54.64 - $61.3 $4.16 Million - $4.67 Million
76,150 New
76,150 $4.26 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.